Disease · MONDO_0045057
Comparisons in its trials35
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 35
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Gabapentin vs Placebo: Incidence of Postoperative Delirium by Study Group | 84 of 350 | 72 of 347 | 697 | NCT00221338 | Trial comparisons |
| Gabapentin vs Placebo: deaths from any cause | 0 of 350 | 1 of 347 | 697 | NCT00221338 | Trial comparisons |
| Gabapentin vs Placebo: serious adverse events | 31 of 350 | 44 of 347 | 697 | NCT00221338 | Trial comparisons |
| Dexmedetomidine vs Propofol: Death at 90 Days | 81 of 214 | 82 of 208 | 422 | NCT01739933 | Trial comparisons |
| Dexmedetomidine vs Propofol: deaths from any cause | 89 of 214 | 86 of 208 | 422 | NCT01739933 | Trial comparisons |
| Dexmedetomidine vs Propofol: serious adverse events | 0 of 214 | 0 of 208 | 422 | NCT01739933 | Trial comparisons |
| Dexmedetomidine vs Control: deaths from any cause | 0 of 80 | 1 of 81 | 161 | NCT02819141 | Trial comparisons |
| Dexmedetomidine vs Control: serious adverse events | 12 of 80 | 5 of 81 | 161 | NCT02819141 | Trial comparisons |
| Suvorexant Arm vs Placebo Arm: deaths from any cause | 1 of 66 | 0 of 57 | 123 | NCT05733286 | Trial comparisons |
| Suvorexant Arm vs Placebo Arm: serious adverse events | 9 of 66 | 9 of 57 | 123 | NCT05733286 | Trial comparisons |
| Ramelteon vs Placebo: deaths from any cause | 3 of 59 | 4 of 61 | 120 | NCT02691013 | Trial comparisons |
| Ramelteon vs Placebo: serious adverse events | 0 of 59 | 0 of 61 | 120 | NCT02691013 | Trial comparisons |
| Ramelteon vs Placebo: Number of Participants With Delirium | 19 of 59 | 22 of 58 | 117 | NCT02691013 | Trial comparisons |
| Guanfacine vs Placebo: deaths from any cause | 9 of 50 | 10 of 50 | 100 | NCT04578886 | Trial comparisons |
| Guanfacine vs Placebo: serious adverse events | 0 of 50 | 0 of 50 | 100 | NCT04578886 | Trial comparisons |
| Intervention Group (Lorazepam & Haloperidol) vs Control Group (Placebo & Haloperidol): deaths from any cause | 10 of 47 | 10 of 43 | 90 | NCT01949662 | Trial comparisons |
| Intervention Group (Lorazepam & Haloperidol) vs Control Group (Placebo & Haloperidol): Number of Participants With Richmond Agitation-Sedation Scale Score >=1 Within 8 hr | 8 of 29 | 22 of 29 | 58 | NCT01949662 | Trial comparisons |
| Intervention Group (Lorazepam & Haloperidol) vs Control Group (Placebo & Haloperidol): serious adverse events | 0 of 29 | 0 of 29 | 58 | NCT01949662 | Trial comparisons |
| Infusion of Dexmedetomidine vs Standard of Care: Resolution of Delirium | 21 of 25 | 14 of 28 | 53 | NCT00351299 | Trial comparisons |
| Infusion of Dexmedetomidine vs Standard of Care: serious adverse events | 0 of 25 | 0 of 28 | 53 | NCT00351299 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0045057/comparisons